To better understand whether kisspeptin is involved in stroke pathophysiology, we tested the hypothesis that kisspeptin immunoreactivity is higher in the brain from patients that suffered either ICH or ICH associated with CAA, compared to controls (who died suddenly from other causes). This evidence concerns the gene KISS1 and Stroke.